Side effects are comparable, though AOD 9604 has more clinical data supporting its safety profile
The Bottom Line Peptide therapy offers a powerful tool for weight loss, appetite control, and metabolic health
Other than that, this is a great company
IGF-1 displays more binding sites for SHP2 (a phosphatase related to growth) and seems more prone to recruit Cbl [121] (an E3 ligase that targets the receptor for ubiquitination and destruction) and thus may explain a different regulatory mechanism not mediated by serine phosphorylation, and thus not so sensitive to metabolic derangements
GHK-Cu occurs naturally in the body and has broader documented effects on skin, wounds, and tissue regeneration
But if they dont get better or get worse, you should talk to a doctor